ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Catheter Precision, Inc. Participates in AF Symposium

FORT MILL, SC / ACCESSWIRE / January 29, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company focused on electrophysiology products is participating in the AF Symposium conference. The AF Symposium is taking place in Boston, Massachusetts from February 1-3, at the Omni Seaport Hotel. The AF Symposium was initiated in 1995 in response to the growing epidemic of atrial fibrillation. Over the past 29 years, the meeting has become a major scientific forum at which healthcare professionals have a unique opportunity to learn about advances in research and therapeutics directly from many of the most eminent investigators in the field. The Electrophysiology product divisions from other large companies will be attending including Medtronic (MDT), Boston Scientific (BSX), Abbott (ABT), and Johnson and Johnson (JNJ).

David Jenkins,CEO of Catheter Precision, said, "Participation in medical device conferences enables us to showcase our products to a dedicated audience of physicians. A conference like AF Symposium is unique in that it is dedicated to electrophysiologists. So, while it may be a smaller gathering it is also a very targeted audience and enables us to show our VIVO mapping system and LockeT suture retention device and generate leads and create additional interest."

About VIVO

Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, there by streamlining workflow and reducing procedure time. VIVO has received marketing clearance from the U.S. FDA and has the CE mark.

About LockeT

Catheter Precision's LockeT is a suture retention device intended to assist in hemostasis after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA.

About Catheter Precision

Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Reincorporated as Ra Medical Systems, Inc. in Delaware in 2018, the Company changed its name to Catheter Precision, Inc. on August 17, 2023.

CONTACTS:

At the Company

David Jenkins 973-691-2000
IR@catheterprecision.com

SOURCE: Catheter Precision, Inc.



View the original press release on accesswire.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.31
+0.31 (0.13%)
AAPL  247.65
+0.95 (0.39%)
AMD  249.80
+17.88 (7.71%)
BAC  52.07
-0.03 (-0.06%)
GOOG  328.38
+6.22 (1.93%)
META  612.96
+8.84 (1.46%)
MSFT  444.06
-10.46 (-2.30%)
NVDA  183.32
+5.25 (2.95%)
ORCL  173.88
-6.04 (-3.36%)
TSLA  431.44
+12.19 (2.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.